Abbott Laboratories (Pakistan) Limited (PSX:ABOT)
1,100.35
-2.15 (-0.20%)
At close: Mar 27, 2025
PSX:ABOT Balance Sheet
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | - | 4,542 | 7,966 | 819.35 | 988.88 | Upgrade
|
Short-Term Investments | - | 495 | 825.8 | 7,800 | 6,500 | Upgrade
|
Cash & Short-Term Investments | 3,853 | 5,037 | 8,792 | 8,619 | 7,489 | Upgrade
|
Cash Growth | -23.50% | -42.71% | 2.00% | 15.10% | 171.58% | Upgrade
|
Accounts Receivable | - | 1,650 | 1,358 | 1,295 | 987.96 | Upgrade
|
Other Receivables | - | 2,430 | 1,329 | 741.78 | 1,281 | Upgrade
|
Receivables | - | 4,123 | 2,720 | 2,070 | 2,302 | Upgrade
|
Inventory | - | 13,290 | 8,856 | 7,006 | 5,226 | Upgrade
|
Prepaid Expenses | - | 279.06 | 262.2 | 70.31 | 102.5 | Upgrade
|
Other Current Assets | - | 470.65 | 1,199 | 666.78 | 582.46 | Upgrade
|
Total Current Assets | - | 23,199 | 21,829 | 18,432 | 15,702 | Upgrade
|
Property, Plant & Equipment | - | 13,375 | 11,989 | 10,006 | 9,070 | Upgrade
|
Other Intangible Assets | - | 12.68 | 26.9 | 49.02 | 66.26 | Upgrade
|
Other Long-Term Assets | - | 13.49 | 11.74 | 12.1 | 13 | Upgrade
|
Total Assets | - | 36,693 | 33,920 | 28,568 | 24,916 | Upgrade
|
Accounts Payable | - | 2,281 | 2,045 | 1,328 | 2,141 | Upgrade
|
Accrued Expenses | - | 4,670 | 4,212 | 4,587 | 3,440 | Upgrade
|
Short-Term Debt | - | - | - | 15.78 | - | Upgrade
|
Current Portion of Leases | - | 105.99 | 120.21 | 93.74 | 189.96 | Upgrade
|
Current Unearned Revenue | - | 610.97 | 565.96 | 460.42 | 480.64 | Upgrade
|
Other Current Liabilities | - | 9,167 | 7,664 | 2,858 | 582.58 | Upgrade
|
Total Current Liabilities | - | 16,835 | 14,607 | 9,343 | 6,834 | Upgrade
|
Long-Term Leases | - | 52.23 | 127.08 | 133.94 | 626.29 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | 519.57 | 499.66 | 269.74 | 227.59 | Upgrade
|
Other Long-Term Liabilities | - | - | - | - | 172.83 | Upgrade
|
Total Liabilities | - | 18,456 | 16,814 | 11,213 | 9,325 | Upgrade
|
Common Stock | - | 979 | 979 | 979 | 979 | Upgrade
|
Retained Earnings | - | 15,821 | 15,068 | 15,483 | 13,844 | Upgrade
|
Comprehensive Income & Other | - | 1,437 | 1,059 | 892.15 | 767.61 | Upgrade
|
Shareholders' Equity | 22,432 | 18,237 | 17,106 | 17,355 | 15,590 | Upgrade
|
Total Liabilities & Equity | - | 36,693 | 33,920 | 28,568 | 24,916 | Upgrade
|
Total Debt | 50.27 | 158.22 | 247.29 | 243.46 | 816.25 | Upgrade
|
Net Cash (Debt) | 3,803 | 4,878 | 8,545 | 8,376 | 6,673 | Upgrade
|
Net Cash Growth | -22.05% | -42.91% | 2.01% | 25.53% | 180.79% | Upgrade
|
Net Cash Per Share | 38.84 | 49.83 | 87.28 | 85.56 | 68.16 | Upgrade
|
Filing Date Shares Outstanding | 97.94 | 97.9 | 97.9 | 97.9 | 97.9 | Upgrade
|
Total Common Shares Outstanding | 97.94 | 97.9 | 97.9 | 97.9 | 97.9 | Upgrade
|
Working Capital | - | 6,364 | 7,222 | 9,089 | 8,868 | Upgrade
|
Book Value Per Share | 229.13 | 186.28 | 174.73 | 177.27 | 159.25 | Upgrade
|
Tangible Book Value | 22,429 | 18,225 | 17,079 | 17,306 | 15,524 | Upgrade
|
Tangible Book Value Per Share | 229.11 | 186.16 | 174.45 | 176.77 | 158.57 | Upgrade
|
Land | - | 23.4 | 23.4 | 23.4 | 23.4 | Upgrade
|
Buildings | - | 1,055 | 786.79 | 582.35 | 529.39 | Upgrade
|
Machinery | - | 18,096 | 17,018 | 14,207 | 12,612 | Upgrade
|
Construction In Progress | - | 2,804 | 1,860 | 1,726 | 911.99 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.